• 17-Ketosteroids, Urine
  • Human T-Cell Lymphotropic Virus (HTLV) I/II Antibody Screen
  • Vitamin A
  • Collagen Crosslinked C-telopeptide
  • Duodenal Mucosal Biopsy, Endoscopic
  • Bilirubin, Direct, Serum
  • UDP-glucuronosyl Transferase 1A6 (UGT1A6) Genotyping
  • Ewing Sarcoma (EWSR1/FLI1 and EWSR1/ERG) by Reverse Transcriptase PCR (RT-PCR), Paraffin
  • Propoxyphene, Serum
  • Measles (Rubeola) Antibody, IgM
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
Medical Test

Turnaround Time
Access to Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants is restricted.